ACADIA Pharmaceuticals Inc. (ACAD) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 268.06M | 283.99M | 278.63M | 264.57M | 244.32M | 259.6M | 250.4M | 241.96M | 205.83M | 231.04M | 211.7M | 165.24M |
| Revenue Growth % | 9.72% | 9.39% | 11.27% | 9.34% | 18.7% | 12.36% | 18.28% | 46.44% | 73.75% | 69.27% | 61.96% | 22.79% |
| Cost of Goods Sold | 24.79M | 26.23M | 21.65M | 20.73M | 20.39M | 21.8M | 18.86M | 18.23M | 22.95M | 17.89M | 14.62M | 7.46M |
| COGS % of Revenue | 9.25% | 9.23% | 7.77% | 7.84% | 8.35% | 8.4% | 7.53% | 7.53% | 11.15% | 7.74% | 6.91% | 4.51% |
| Gross Profit | 243.27M | 257.76M | 256.99M | 243.83M | 223.93M | 237.8M | 231.54M | 223.73M | 182.88M | 213.15M | 197.08M | 157.78M |
| Gross Margin % | 90.75% | 90.77% | 92.23% | 92.16% | 91.65% | 91.6% | 92.47% | 92.47% | 88.85% | 92.26% | 93.09% | 95.49% |
| Gross Profit Growth % | 8.64% | 8.4% | 10.99% | 8.98% | 22.44% | 11.56% | 17.49% | 41.8% | 56.58% | 58.98% | 53.27% | 19.62% |
| Operating Expenses | 247.89M | 240.37M | 221.23M | 211.46M | 204.63M | 84.3M | 199.9M | 193.3M | 167.67M | 178.21M | 254.85M | 154.74M |
| OpEx % of Revenue | 92.47% | 84.64% | 79.4% | 79.93% | 83.76% | 32.47% | 79.83% | 79.89% | 81.46% | 77.13% | 120.38% | 93.65% |
| Selling, General & Admin | 171.02M | 155.62M | 133.4M | 133.51M | 126.37M | 130.08M | 133.29M | 117.06M | 107.99M | 111.47M | 97.89M | 95.97M |
| SG&A % of Revenue | 63.8% | 54.8% | 47.88% | 50.46% | 51.72% | 50.11% | 53.23% | 48.38% | 52.47% | 48.24% | 46.24% | 58.08% |
| Research & Development | 76.87M | 84.76M | 87.83M | 77.95M | 78.27M | 100.73M | 66.61M | 76.23M | 59.68M | 66.74M | 156.96M | 58.77M |
| R&D % of Revenue | 28.68% | 29.85% | 31.52% | 29.46% | 32.03% | 38.8% | 26.6% | 31.51% | 28.99% | 28.89% | 74.14% | 35.57% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.62M | 17.39M | 35.76M | 32.37M | 19.29M | 153.5M | 31.64M | 30.44M | 15.21M | 34.94M | -57.78M | 3.04M |
| Operating Margin % | -1.72% | 6.12% | 12.83% | 12.24% | 7.9% | 59.13% | 12.64% | 12.58% | 7.39% | 15.12% | -27.29% | 1.84% |
| Operating Income Growth % | -123.93% | -88.67% | 12.99% | 6.36% | 26.82% | 339.28% | 154.77% | 902.21% | 128.39% | 175.86% | -87.18% | 109.02% |
| EBITDA | -4.62M | 26.32M | 38.71M | 35.31M | 22.24M | 158.72M | 31.64M | 33.01M | 20.74M | 36.58M | -56.05M | 4.8M |
| EBITDA Margin % | -1.72% | 9.27% | 13.89% | 13.35% | 9.1% | 61.14% | 12.64% | 13.64% | 10.08% | 15.83% | -26.48% | 2.91% |
| EBITDA Growth % | -120.75% | -83.42% | 22.32% | 6.97% | 7.25% | 333.88% | 156.45% | 587.24% | 139.01% | 180.27% | -84.63% | 114.49% |
| D&A (Non-Cash Add-back) | 0 | 0 | 2.95M | 2.94M | 2.95M | 5.21M | 0 | 2.57M | 5.53M | 1.64M | 1.72M | 1.77M |
| EBIT | -4.62M | 26.32M | 44.59M | 32.37M | 19.29M | 6.99M | 31.64M | 30.44M | 15.21M | 34.94M | -57.78M | 3.04M |
| Net Interest Income | 0 | 8.33M | 8.25M | 7.24M | 7.9M | 7.01M | 6.59M | 6.36M | 5.51M | 4.76M | 4.13M | 4.55M |
| Interest Income | 0 | 8.33M | 8.25M | 7.24M | 7.9M | 7.01M | 6.59M | 6.36M | 5.51M | 4.76M | 4.13M | 4.55M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 8.6M | 8.93M | 8.84M | 7.84M | 8.49M | 7.58M | 7.16M | 6.75M | 5.79M | 4.76M | 5.63M | 3.31M |
| Pretax Income | 3.98M | 26.32M | 44.59M | 40.21M | 27.78M | 161.09M | 38.81M | 37.18M | 21M | 39.7M | -52.14M | 6.34M |
| Pretax Margin % | 1.49% | 9.27% | 16% | 15.2% | 11.37% | 62.05% | 15.5% | 15.37% | 10.2% | 17.18% | -24.63% | 3.84% |
| Income Tax | 344K | -247.25M | -27.18M | 13.54M | 8.79M | 17.34M | 6.04M | 3.79M | 4.45M | -6.09M | 13.03M | 5.23M |
| Effective Tax Rate % | 8.64% | -939.43% | -60.96% | 33.68% | 31.65% | 10.77% | 15.57% | 10.2% | 21.17% | -15.35% | -24.99% | 82.44% |
| Net Income | 3.64M | 273.57M | 71.78M | 26.67M | 18.99M | 143.74M | 32.77M | 33.39M | 16.55M | 45.8M | -65.18M | 1.11M |
| Net Margin % | 1.36% | 96.33% | 25.76% | 10.08% | 7.77% | 55.37% | 13.08% | 13.8% | 8.04% | 19.82% | -30.79% | 0.67% |
| Net Income Growth % | -80.84% | 90.32% | 119.07% | -20.14% | 14.69% | 213.87% | 150.27% | 2897.22% | 138.48% | 209.76% | -139.77% | 103.28% |
| Net Income (Continuing) | 3.64M | 273.57M | 71.78M | 26.67M | 18.99M | 143.74M | 32.77M | 33.39M | 16.55M | 45.8M | -65.18M | 1.11M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.02 | 1.60 | 0.42 | 0.16 | 0.11 | 0.86 | 0.20 | 0.20 | 0.10 | 0.28 | -0.40 | 0.01 |
| EPS Growth % | -81.82% | 86.05% | 110% | -20% | 10% | 207.14% | 150% | - | 137.04% | 207.69% | -135.29% | 103.24% |
| EPS (Basic) | 0.02 | 1.62 | 0.43 | 0.16 | 0.11 | 0.87 | 0.20 | 0.20 | 0.10 | 0.28 | -0.40 | 0.01 |
| Diluted Shares Outstanding | 172.71M | 171.36M | 170.65M | 168.68M | 167.67M | 166.36M | 166.18M | 166.17M | 166.62M | 166.51M | 164.23M | 165.05M |
| Basic Shares Outstanding | 170.52M | 169.34M | 168.84M | 167.83M | 166.81M | 166.53M | 165.97M | 165.55M | 164.8M | 164.81M | 164.23M | 163.46M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |